GEEN Biotechnology
Istanbul · Founded 2015
About GEEN Biotechnology
GEEN Biotechnology is a synthetic biology company developing master cells & genetic technologies for industrial production of biomolecules. It developing especially genome editing related (e.g. CRISPR/Cas9) genetic technologies and working on mostly various yeast cells and recently putting effort into industrializing minimal cells. GEEN Biotechnology is your high-tech genetic eng. partner through drug and industrial biotech product development.
Company Facts
- Founded: 2015
- Legal name: GEEN Biotechnology, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $120.0K
- Funding stage: Seed
- Last round: Non-Equity Assistance (Jan 2018)
- Website: geenbio.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/geen-biotechnology-8374279 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.